Could an old malaria drug help fight liver cancer?
NCT ID NCT03037437
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study tested whether adding hydroxychloroquine (a malaria drug) to the standard cancer drug sorafenib could better control advanced liver cancer. It included 64 adults whose cancer could not be cured by surgery or transplant. The goal was to see if the combination slowed tumor growth compared to sorafenib alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Health Cancer Center
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.